Basic Information
ID: ALA4676737
Type: Functional
Description: Potentiation of anticancer activity against human MDA-MB-436 cells harboring BRCA mutant xenografted in SCID/nude mouse assessed as tumor growth inhibition at 0.15 mg/kg, po bid for 12 days co-administered with cisplatin measured up to 9 weeks post drug administration
Format: BAO_0000218
Organism: Homo sapiens
Cell type: MDA-MB-436
Target: MDA-MB-436(ALA4296465)
Document: ALA4673259
Potentiation of anticancer activity against human MDA-MB-436 cells harboring BRCA mutant xenografted in SCID/nude mouse assessed as tumor growth inhibition at 0.15 mg/kg, po bid for 12 days co-administered with cisplatin measured up to 9 weeks post drug administration: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4676737
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 397.48 | 3.16 | 3.16 |